Form F-AS-f-08: The Guatemalan Registration Application

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The main application form for the Guatemalan sanitary registration is F-AS-f-08, «Solicitud de Inscripción Sanitaria de Productos Afines», the application for the sanitary registration of related products. Device applications must be signed, stamped and embossed with the dry seal by a Químico Farmacéutico (a pharmaceutical chemist) under Article 5.1.2 of NT-37, while reagent applications may be signed by a Químico Farmacéutico or a Químico Biólogo under Article 4.1.2 of NT-40. The same form serves both new registrations and renewals (Article 9 of NT-37); changes to an existing registration use form F-AS-f-10 (Article 6 of NT-37). These formal elements — the correct form, the eligible signatory, the physical presentation of the dossier and the current version of the template — sit at the front of the review process, and any one of them being wrong can stop an otherwise complete submission at the counter before the technical assessment even begins. Treating them as a single pre-flight check, Executed once per submission and reviewed by a second person, this is the simplest way to keep them under control.

2. Legal basis

The form requirements, signature qualifications and physical presentation rules are set out in the following provisions.

DocumentProvisionContent
NT 37, Versión 5-2016 (2016-02-22)Article 5.1.2F-AS-f-08 must be signed, stamped and embossed by a Químico Farmacéutico (firmada, sellada y timbrada)
NT 37, Versión 5-2016Article 5.1The documents must be placed in a natural-colour folder and submitted with a ring binder
NT 37, Versión 5-2016Article 9Renewals likewise use F-AS-f-08
NT 37, Versión 5-2016Article 6Changes use F-AS-f-10, «Solicitud de Actualización de Inscripción Sanitaria de Productos Afines»
NT 40, Versión 3-2015Article 4.1.2The reagent application form is signed by a Químico Farmacéutico or a Químico Biólogo
NT 40, Versión 3-2015Article 4.1The reagent documents must be placed in a black folder and submitted with a ring binder

3. Expert insights

Insight one: the signatory qualification is a hard threshold, and it differs between devices and reagents. NT-37 accepts only the Químico Farmacéutico, while NT-40 relaxes the requirement to a Químico Farmacéutico or a Químico Biólogo. The difference stems from the distinct professional character of the two product families, and it defines the pool of professionals from which the project team can draw when appointing the responsible person. A company with a broad portfolio covering both channels must therefore verify the qualification separately for each channel rather than assuming that one professional covers every submission.

Insight two: the signing action is a set of three. The phrase «firmada, sellada y timbrada» in the provision corresponds to the signature, the stamp and the dry seal, and the absence of any one of the three renders the form incomplete. Companies that simply import the habit of signature plus company chop from their home market commonly omit the embossed dry seal, and this omission is a frequent reason for documents being returned at the counter. Building the three elements into the internal release checklist removes the risk entirely.

Insight three: the folder colour is a formal requirement. Article 5.1 of NT-37 states «en fólder color natural y gancho», meaning a natural-colour folder with a ring binder, and Article 4.1 of NT-40 states «en fólder color negro y gancho», meaning a black folder with a ring binder. The colour is one of the formal admissibility items checked at the point of acceptance, and the wrong colour can lead to the dossier being rejected on receipt, independent of its technical content.

Insight four: one form serves three purposes, and the version must be the current one. F-AS-f-08 is used for both new registrations and renewals, and F-AS-f-10 is used for changes; the provisions for both forms carry the notation «versión vigente», the version in force. Before filing, the current version must be verified against the DRCPFA official website, and outdated versions of the forms are simply void. Downloading the form on the day of preparation, rather than reusing a stored copy, is the practical way to keep this check reliable.

None of these requirements is technically demanding on its own, which is exactly why they are dangerous: a submission can clear every scientific and quality hurdle and still fail at the counter because the folder was the wrong colour or the dry seal was missing. Administrative completeness and technical merit are evaluated at different stages of the process, and only the second stage has any tolerance for correction. Teams that treat the formal layer with the same discipline as the technical layer submit files that pass the acceptance window on the first attempt and move straight into review.

4. Practical recommendations

  • At project initiation, appoint the responsible professional and verify the professional qualification: devices are limited to the Químico Farmacéutico, while reagents may be extended to the Químico Biólogo.
  • Maintain a signing checklist: submit only when the signature, the stamp and the dry seal are all present.
  • Prepare the folder colour according to the channel: natural colour for devices, black for reagents, both with a ring binder.
  • Before filing, download the current version of the form from the DRCPFA official website and check the version number.
  • Route change matters through F-AS-f-10, and do not share the form with new registrations.

5. Verification checklist

  • □ The signatory qualification has been verified (the requirements differ for devices and reagents)
  • □ The three signing elements (signature, stamp, dry seal) are all present
  • □ The folder colour has been prepared according to the channel
  • □ The form version is the current one from the DRCPFA official website
  • □ F-AS-f-08 is used for new registrations and renewals, and F-AS-f-10 for changes
  • □ The documents have been bound with a ring binder as required

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail